Range Low Price High Price Comment
30 days $17.56 $26.56 Thursday, 28th Mar 2024 ACAD stock ended at $18.49. This is 1.59% more than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 2.49% from a day low at $18.05 to a day high of $18.50.
90 days $17.56 $31.82
52 weeks $17.56 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
2023-05-05 $21.66 $22.04 $21.25 $21.93 1 114 990
2023-05-04 $21.06 $21.69 $20.63 $21.55 1 087 265
2023-05-03 $21.46 $21.85 $21.08 $21.20 1 584 387
2023-05-02 $21.62 $21.90 $21.28 $21.38 1 164 894
2023-05-01 $21.18 $21.86 $21.16 $21.75 1 238 505
2023-04-28 $20.51 $21.49 $20.42 $21.33 1 367 094
2023-04-27 $20.39 $20.61 $20.14 $20.50 835 390
2023-04-26 $20.05 $20.43 $19.91 $20.31 980 023
2023-04-25 $20.13 $20.30 $19.93 $20.11 748 203
2023-04-24 $20.08 $20.19 $19.90 $20.14 652 774
2023-04-21 $19.92 $20.12 $19.71 $20.09 1 007 614
2023-04-20 $19.99 $20.41 $19.66 $19.97 1 125 069
2023-04-19 $19.64 $20.17 $19.53 $20.02 1 290 399
2023-04-18 $19.49 $19.82 $19.05 $19.72 1 810 278
2023-04-17 $18.13 $19.46 $18.08 $19.37 2 192 750
2023-04-14 $18.48 $18.48 $17.75 $17.99 1 451 897
2023-04-13 $18.46 $18.88 $18.33 $18.52 1 523 702
2023-04-12 $18.31 $18.55 $18.14 $18.34 1 181 784
2023-04-11 $17.78 $18.22 $17.78 $18.09 1 691 253
2023-04-10 $18.14 $18.17 $17.71 $17.80 987 545
2023-04-06 $18.16 $18.47 $18.12 $18.35 1 266 418
2023-04-05 $18.44 $18.70 $18.24 $18.28 882 183
2023-04-04 $19.03 $19.14 $18.20 $18.48 1 365 235
2023-04-03 $18.68 $19.07 $18.66 $18.93 691 016
2023-03-31 $18.89 $19.10 $18.65 $18.82 878 723
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT